Enhanced Expression of Resistin-like Molecule Beta in Human Colon Cancer and Its Clinical Significance
- 2 July 2008
- journal article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 54 (2), 274-281
- https://doi.org/10.1007/s10620-008-0355-2
Abstract
Previous studies have indicated that resistin-like molecule beta (RELMβ), an intestinal goblet cell-specific protein, is markedly increased in the intestinal tumors of min mice and over-expressed in a human colon cancer cell line. We hypothesized that RELMβ might be enhanced in human colon cancer. The aim of this study was to examine the clinical importance of RELMβ expression in colon cancer patients and to correlate its expression with various clinicopathological parameters, upstream regulatory molecule expression, tumor proliferative capacity, and patients’ survival. Of the 80 colon cancer patients studied, 65 (81.25%) tested positive for RELMβ, mainly in the cytoplasm of colon mucosa. Contrasting sharply with the strongly RELMβ-positive tumors, normal colon mucous membrane was negative or weakly positive. RELMβ positivity in colon cancer was correlated with histological grade of differentiation and lymph node metastasis, but not with age, gender, tumor location and size, tumor infiltration, Dukes’ stage, liver metastasis, and venous invasion. RELMβ expression was significantly correlated with the expression of transcription factor CDX-2 (P < 0.01) but not with that of proliferative index Ki-67 (P > 0.05). The mean postoperative survival time (2.76 years) of RELMβ-positive patients was significantly longer than that (1.26 years) of RELMβ-negative patients (P = 0.032). These findings support evidence of the enhanced RELMβ expression in colon cancer patients and suggest that further investigation is warranted to explore the role of RELMβ in colon cancer.Keywords
This publication has 35 references indexed in Scilit:
- MUC1 cell surface mucin is a critical element of the mucosal barrier to infectionJCI Insight, 2007
- Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: Physiological distribution and pathological significanceProgress in Histochemistry and Cytochemistry, 2007
- Regulation of RELM/FIZZ isoform expression byCdx2in response to innate and adaptive immune stimulation in the intestineAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- The role of Cdx genes in the mammalian gutGut, 2004
- Mucin Macromolecules in Normal, Adenomatous, and Carcinomatous Colon: Evidence for the NeotransformationMacromolecular Bioscience, 2004
- The current biology of resistinJournal of Internal Medicine, 2004
- Bacterial colonization leads to the colonic secretion of RELMβ/FIZZ2, a novel goblet cell-specific proteinGastroenterology, 2003
- Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2Oncogene, 2001
- FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000
- TheCdx-1andCdx-2homeobox genes in the intestineBiochemistry and Cell Biology, 1998